Published in JAMA on December 12, 2007
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature (2010) 5.01
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study. BMJ (2009) 4.44
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies. BMJ (2011) 4.05
Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study. BMJ (2013) 2.92
Prevalence and incidence of hypertension from 1995 to 2005: a population-based study. CMAJ (2008) 2.41
Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2013) 2.15
Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records. Diabetes Care (2009) 2.00
Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study. PLoS Med (2009) 1.94
Differential hydrogen/deuterium exchange mass spectrometry analysis of protein-ligand interactions. Expert Rev Proteomics (2011) 1.45
The risk of fractures associated with thiazolidinediones: a self-controlled case-series study. PLoS Med (2009) 1.40
Mortality among patients with hypertension from 1995 to 2005: a population-based study. CMAJ (2008) 1.26
Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab (2011) 1.25
Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis. Pharmacoepidemiol Drug Saf (2009) 1.18
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis. Cardiovasc Diabetol (2013) 1.17
Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity. Chem Biol (2012) 1.16
Future innovations in anti-platelet therapies. Br J Pharmacol (2008) 1.13
Thiazolidinediones: do harms outweigh benefits? CMAJ (2008) 1.09
Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of grade 8 girls. BMC Public Health (2011) 1.09
KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol (2013) 1.08
The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies. BMC Cardiovasc Disord (2014) 1.08
Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study. Drug Saf (2012) 1.07
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol (2009) 1.04
PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty. J Lipid Res (2012) 1.04
Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates. Health Serv Res (2012) 1.00
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study). Cardiovasc Diabetol (2008) 0.99
Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability. Mediators Inflamm (2008) 0.99
Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation. J Thromb Haemost (2009) 0.96
Rosiglitazone and myocardial infarction in patients previously prescribed metformin. PLoS One (2009) 0.94
Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study. Acta Diabetol (2014) 0.94
The role of peroxisome proliferator-activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus. Diabetes Obes Metab (2010) 0.93
PPARgamma-independent increase in glucose uptake and adiponectin abundance in fat cells. Endocrinology (2011) 0.92
Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data. Inflamm Bowel Dis (2011) 0.91
Ciprofloxacin-induced theophylline toxicity: a population-based study. Eur J Clin Pharmacol (2011) 0.91
Thiazolidinediones, cardiovascular disease and cardiovascular mortality: translating research into action for diabetes (TRIAD). Pharmacoepidemiol Drug Saf (2010) 0.90
Effects of long-term pioglitazone treatment on peripheral and central markers of aging. PLoS One (2010) 0.90
Trimethoprim/sulfamethoxazole-induced phenytoin toxicity in the elderly: a population-based study. Br J Clin Pharmacol (2011) 0.89
Comparing the cohort design and the nested case-control design in the presence of both time-invariant and time-dependent treatment and competing risks: bias and precision. Pharmacoepidemiol Drug Saf (2012) 0.88
Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus. Mayo Clin Proc (2011) 0.87
Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data. PLoS One (2011) 0.86
Insulin receptor-independent upregulation of cellular glucose uptake. Int J Obes (Lond) (2012) 0.86
Cleavage of protein kinase D after acute hypoinsulinemia prevents excessive lipoprotein lipase-mediated cardiac triglyceride accumulation. Diabetes (2009) 0.85
Challenges in Drug Discovery for Thiazolidinedione Substitute. Yao Xue Xue Bao (2011) 0.85
Optimal therapy of type 2 diabetes: a controversial challenge. Aging (Albany NY) (2014) 0.85
A review of cardiovascular risks associated with medications used to treat type-2 diabetes mellitus. P T (2009) 0.85
Clinical Use of PPARgamma Ligands in Cancer. PPAR Res (2008) 0.84
Combination of a peroxisome proliferator-activated receptor-gamma agonist and an angiotensin II receptor blocker attenuates myocardial fibrosis and dysfunction in type 2 diabetic rats. J Diabetes Investig (2013) 0.84
Trends in Antihyperglycemic Medication Prescriptions and Hypoglycemia in Older Adults: 2002-2013. PLoS One (2015) 0.84
Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study. BMC Public Health (2014) 0.83
New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor. Clin Interv Aging (2008) 0.83
PPARγ activator, rosiglitazone: Is it beneficial or harmful to the cardiovascular system? World J Cardiol (2011) 0.82
PPARγ activation redirects macrophage cholesterol from fecal excretion to adipose tissue uptake in mice via SR-BI. Biochem Pharmacol (2011) 0.81
Thrap3 docks on phosphoserine 273 of PPARγ and controls diabetic gene programming. Genes Dev (2014) 0.81
Cardiovascular safety profile of currently available diabetic drugs. Ochsner J (2014) 0.81
Rosiglitazone: can meta-analysis accurately estimate excess cardiovascular risk given the available data? Re-analysis of randomized trials using various methodologic approaches. BMC Res Notes (2009) 0.79
Fam57b (family with sequence similarity 57, member B), a novel peroxisome proliferator-activated receptor γ target gene that regulates adipogenesis through ceramide synthesis. J Biol Chem (2012) 0.78
A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors. Br J Clin Pharmacol (2015) 0.78
Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes: a cohort study. Allergy Asthma Clin Immunol (2014) 0.77
Treating the elderly diabetic patient: special considerations. Diabetes Metab Syndr Obes (2014) 0.77
Use of rosiglitazone before and after vascular injury in hypercholesterolemic rabbits: Assessment of neointimal formation. Thromb J (2008) 0.77
Thiazolidinediones and cardiovascular risk - a question of balance. Curr Cardiol Rev (2009) 0.77
Effects of rosiglitazone on contralateral iliac artery after vascular injury in hypercholesterolemic rabbits. Thromb J (2008) 0.77
Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database. BMC Clin Pharmacol (2011) 0.77
Thiazolidinedione drugs promote onset, alter characteristics, and increase mortality of ischemic ventricular fibrillation in pigs. Cardiovasc Drugs Ther (2012) 0.76
Cardiovascular effects of noncardiovascular drugs. Circulation (2009) 0.76
Peroxisome proliferator-activated receptor agonists: do they increase cardiovascular risk? PPAR Res (2009) 0.76
Safety and efficacy of rosiglitazone in the elderly diabetic patient. Vasc Health Risk Manag (2009) 0.76
Is glucose normalization an evidence-based treatment for patients with type 2 diabetes mellitus? Nat Clin Pract Endocrinol Metab (2008) 0.75
Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside. Biologics (2008) 0.75
Thiazolidinediones increased risk for heart failure, myocardial infarction, and death in older patients with type 2 diabetes. ACP J Club (2008) 0.75
Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study. J Clin Psychopharmacol (2015) 0.75
Management of Diabetic Nephropathy in the Elderly: Special Considerations. J Nephrol Ther (2012) 0.75
Operative trends and physician treatment costs associated with Dupuytren's disease in Canada. Can J Plast Surg (2013) 0.75
Is thiazolidinediones use a factor in delaying the need for insulin therapy in type 2 patients with diabetes? A population-based cohort study. BMJ Open (2012) 0.75
Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies. BMC Cardiovasc Disord (2016) 0.75
Lay media reporting of rosiglitazone risk: extent, messaging and quality of reporting. Cardiovasc Diabetol (2009) 0.75
Cycling our way to fit fat. Physiol Rep (2017) 0.75
Effect of aspirin use on thiazolidinediones and cardiovascular events. JAMA (2008) 0.75
[Diabetes in the elderly]. Z Gerontol Geriatr (2012) 0.75
Comparative Effectiveness for Glycemic Control in Older Adults with Diabetes. Curr Geriatr Rep (2017) 0.75
Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ (2009) 9.83
Unintended medication discrepancies at the time of hospital admission. Arch Intern Med (2005) 8.94
Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet (2007) 7.36
Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. Ann Intern Med (2015) 7.13
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA (2007) 7.11
Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med (2006) 7.01
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ (2009) 6.21
Hyperbaric oxygen for carbon monoxide poisoning : a systematic review and critical analysis of the evidence. Toxicol Rev (2005) 5.75
Risk of incident diabetes among patients treated with statins: population based study. BMJ (2013) 5.40
Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study. Ann Intern Med (2013) 5.34
Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA (2011) 5.33
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ (2010) 4.73
A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals. J Clin Epidemiol (2009) 4.48
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study. BMJ (2009) 4.44
Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Ann Intern Med (2013) 4.35
Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario. Can Fam Physician (2011) 4.13
Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med (2011) 4.11
Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol (2005) 3.76
Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA (2004) 3.61
Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med (2012) 3.52
Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care (2003) 3.45
Antipsychotic drugs and hyperglycemia in older patients with diabetes. Arch Intern Med (2009) 3.43
Drugs and the QT interval - caveat doctor. N Engl J Med (2004) 3.29
Epidural anaesthesia and survival after intermediate-to-high risk non-cardiac surgery: a population-based cohort study. Lancet (2008) 3.22
The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med (2012) 3.10
Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. JAMA (2009) 3.08
Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med (2008) 3.06
Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA (2005) 3.05
Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care (2005) 3.02
Comparing hierarchical modeling with traditional logistic regression analysis among patients hospitalized with acute myocardial infarction: should we be analyzing cardiovascular outcomes data differently? Am Heart J (2003) 2.88
Statins and the risk of herpes zoster: a population-based cohort study. Clin Infect Dis (2013) 2.74
Revisiting Rose: strategies for reducing coronary heart disease. BMJ (2006) 2.53
Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ (2008) 2.52
Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Med (2011) 2.51
Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals. JAMA (2012) 2.47
Reduced screening mammography among women with diabetes. Arch Intern Med (2005) 2.44
Facing up to the prescription opioid crisis. BMJ (2011) 2.43
The burden of premature opioid-related mortality. Addiction (2014) 2.42
Testing multiple statistical hypotheses resulted in spurious associations: a study of astrological signs and health. J Clin Epidemiol (2006) 2.35
Outcomes and processes of care related to preoperative medical consultation. Arch Intern Med (2010) 2.34
Proliferation of prenatal ultrasonography. CMAJ (2010) 2.33
Variation in nursing home antipsychotic prescribing rates. Arch Intern Med (2007) 2.30
Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department. Circulation (2010) 2.29
Variation in the practice of preoperative medical consultation for major elective noncardiac surgery: a population-based study. Anesthesiology (2012) 2.26
Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study. BMJ (2011) 2.20
Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly. Arch Intern Med (2003) 2.18
Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol (2007) 2.15
Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study. Diabetes Care (2013) 2.04
Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study. BMJ (2006) 2.03
Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs. Pharmacoepidemiol Drug Saf (2007) 1.98
The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat (2007) 1.98
Relationship between avoidable hospitalizations for diabetes mellitus and income level. Arch Intern Med (2003) 1.95
Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study. PLoS Med (2009) 1.94
Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J (2008) 1.92
New fibrate use and acute renal outcomes in elderly adults: a population-based study. Ann Intern Med (2012) 1.91
Sex-and age-based differences in the delivery and outcomes of critical care. CMAJ (2007) 1.91
Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study. Arch Intern Med (2010) 1.87
Administrative data algorithms can describe ambulatory physician utilization. Health Serv Res (2007) 1.86
Markers of access to and quality of primary care for aboriginal people in Ontario, Canada. Am J Public Health (2003) 1.85
Early deaths in patients with heart failure discharged from the emergency department: a population-based analysis. Circ Heart Fail (2010) 1.83
Temporal trends in the use of percutaneous coronary intervention and coronary artery bypass surgery in New York State and Ontario. Circulation (2010) 1.82
Regional differences in process of care and outcomes for older acute myocardial infarction patients in the United States and Ontario, Canada. Circulation (2006) 1.78
Use of other opioids during methadone therapy: a population-based study. Addiction (2012) 1.72
Impact of the choice of benchmark on the conclusions of hospital report cards. Am Heart J (2004) 1.72
Rates of hemorrhage during warfarin therapy for atrial fibrillation. CMAJ (2012) 1.68
The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. J Clin Psychopharmacol (2008) 1.66
Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study. Nephrol Dial Transplant (2010) 1.65
Persistence with therapy among patients treated with warfarin for atrial fibrillation. Arch Intern Med (2012) 1.65
Oral bisphosphonate use in the elderly is not associated with acute kidney injury. Kidney Int (2012) 1.64
Statins and intracerebral hemorrhage: a retrospective cohort study. Arch Neurol (2011) 1.63
The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care (2007) 1.61
A risk quantification instrument for acute acetaminophen overdose patients treated with N-acetylcysteine. Ann Emerg Med (2005) 1.60
Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study. J Invest Dermatol (2012) 1.59
Opioid dose and risk of road trauma in Canada: a population-based study. JAMA Intern Med (2013) 1.59
Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis. Am J Epidemiol (2006) 1.59
Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J (2007) 1.58
Regional effects of satellite haemodialysis units on renal replacement therapy in non-urban Ontario, Canada. Nephrol Dial Transplant (2007) 1.58
Both clinical epidemiology and population health perspectives can define the role of health care in reducing health disparities. J Clin Epidemiol (2005) 1.58
Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Arch Intern Med (2005) 1.56
Neighborhood income and stroke care and outcomes. Neurology (2012) 1.56